HD Immune

Huntington's Disease (HD) is a rare neurological disease with a fatal outcome that cannot be cured - to date no drug has been developed that can ameliorate the symptoms. Because of this urgent unmet medical need, HD Immune’s aim is to develop a monoclonal antibody, which can interfere with the disease progression, delaying further clinical symptom development.